Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants

Background Genome sequencing coupled with electronic heath record data can uncover medically important genetic variation. Interpretation of rare genetic variation and its role in mediating cardiovascular phenotypes is confounded by variants of uncertain significance. Methods and Results We analyzed...

Full description

Bibliographic Details
Main Authors: Tess D. Pottinger, Megan J. Puckelwartz, Lorenzo L. Pesce, Avery Robinson, Samuel Kearns, Jennifer A. Pacheco, Laura J. Rasmussen‐Torvik, Maureen E. Smith, Rex Chisholm, Elizabeth M. McNally
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.013808
_version_ 1818775043483631616
author Tess D. Pottinger
Megan J. Puckelwartz
Lorenzo L. Pesce
Avery Robinson
Samuel Kearns
Jennifer A. Pacheco
Laura J. Rasmussen‐Torvik
Maureen E. Smith
Rex Chisholm
Elizabeth M. McNally
author_facet Tess D. Pottinger
Megan J. Puckelwartz
Lorenzo L. Pesce
Avery Robinson
Samuel Kearns
Jennifer A. Pacheco
Laura J. Rasmussen‐Torvik
Maureen E. Smith
Rex Chisholm
Elizabeth M. McNally
author_sort Tess D. Pottinger
collection DOAJ
description Background Genome sequencing coupled with electronic heath record data can uncover medically important genetic variation. Interpretation of rare genetic variation and its role in mediating cardiovascular phenotypes is confounded by variants of uncertain significance. Methods and Results We analyzed the whole genome sequence of 900 racially and ethnically diverse biobank participants selected from a single US center. Participants were equally divided among European, African, Hispanic, and mixed races/ethnicities. We evaluated the American College of Medical Genetics and Genomics medically actionable list of 59 genes, focusing on the cardiac genes. Variation was interpreted using the most recent reports in ClinVar, a database of medically relevant human variation. We identified 19 individuals with pathogenic or likely pathogenic variants in cardiac actionable genes (2%) and found evidence of related clinical correlates in the electronic health record. Participants of African ancestry, compared with those of European ancestry, had more variants of uncertain significance in the medically actionable genes including the 30 cardiac actionable genes, even when normalized to total variant count per person. Longitudinal measures of left ventricle size from ≈400 biobank participants (1723 patient‐years) were correlated with genetic findings. The presence of ≥1 uncertain variant in the actionable cardiac genes and a cardiomyopathy diagnosis correlated with increased left ventricular internal diameter in diastole and in systole. In particular, MYBPC3 was identified as a gene with excess variants of uncertain significance. Conclusions These data indicate that a subset of uncertain genetic variants may confer risk and should not be considered benign.
first_indexed 2024-12-18T10:50:46Z
format Article
id doaj.art-4c41541b75f44159a997a45e78137fd0
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-18T10:50:46Z
publishDate 2020-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-4c41541b75f44159a997a45e78137fd02022-12-21T21:10:27ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-02-019310.1161/JAHA.119.013808Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank ParticipantsTess D. Pottinger0Megan J. Puckelwartz1Lorenzo L. Pesce2Avery Robinson3Samuel Kearns4Jennifer A. Pacheco5Laura J. Rasmussen‐Torvik6Maureen E. Smith7Rex Chisholm8Elizabeth M. McNally9Center for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILComputation Institute University of Chicago Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILDepartment of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILCenter for Genetic Medicine Northwestern University Feinberg School of Medicine Chicago ILBackground Genome sequencing coupled with electronic heath record data can uncover medically important genetic variation. Interpretation of rare genetic variation and its role in mediating cardiovascular phenotypes is confounded by variants of uncertain significance. Methods and Results We analyzed the whole genome sequence of 900 racially and ethnically diverse biobank participants selected from a single US center. Participants were equally divided among European, African, Hispanic, and mixed races/ethnicities. We evaluated the American College of Medical Genetics and Genomics medically actionable list of 59 genes, focusing on the cardiac genes. Variation was interpreted using the most recent reports in ClinVar, a database of medically relevant human variation. We identified 19 individuals with pathogenic or likely pathogenic variants in cardiac actionable genes (2%) and found evidence of related clinical correlates in the electronic health record. Participants of African ancestry, compared with those of European ancestry, had more variants of uncertain significance in the medically actionable genes including the 30 cardiac actionable genes, even when normalized to total variant count per person. Longitudinal measures of left ventricle size from ≈400 biobank participants (1723 patient‐years) were correlated with genetic findings. The presence of ≥1 uncertain variant in the actionable cardiac genes and a cardiomyopathy diagnosis correlated with increased left ventricular internal diameter in diastole and in systole. In particular, MYBPC3 was identified as a gene with excess variants of uncertain significance. Conclusions These data indicate that a subset of uncertain genetic variants may confer risk and should not be considered benign.https://www.ahajournals.org/doi/10.1161/JAHA.119.013808biobankcardiomyopathyleft ventriclemedically actionable genesvariants of uncertain significance
spellingShingle Tess D. Pottinger
Megan J. Puckelwartz
Lorenzo L. Pesce
Avery Robinson
Samuel Kearns
Jennifer A. Pacheco
Laura J. Rasmussen‐Torvik
Maureen E. Smith
Rex Chisholm
Elizabeth M. McNally
Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
biobank
cardiomyopathy
left ventricle
medically actionable genes
variants of uncertain significance
title Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants
title_full Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants
title_fullStr Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants
title_full_unstemmed Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants
title_short Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants
title_sort pathogenic and uncertain genetic variants have clinical cardiac correlates in diverse biobank participants
topic biobank
cardiomyopathy
left ventricle
medically actionable genes
variants of uncertain significance
url https://www.ahajournals.org/doi/10.1161/JAHA.119.013808
work_keys_str_mv AT tessdpottinger pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT meganjpuckelwartz pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT lorenzolpesce pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT averyrobinson pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT samuelkearns pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT jenniferapacheco pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT laurajrasmussentorvik pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT maureenesmith pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT rexchisholm pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants
AT elizabethmmcnally pathogenicanduncertaingeneticvariantshaveclinicalcardiaccorrelatesindiversebiobankparticipants